Back

7/10
#NephJC Chat consensus?

We need more data & accelerated approvals using surrogate end-points may not be a bad thing at all.

& Ahem, after rigorous trials & rounds of approval, there's the formidable next challenge- COST!

Very adequately put by @hswapnil (https://twitter.com/hswapnil/status/1661188894526717952?s=20)